Non-Clinical Strategies for Ensuring Cosmetic Product Safety

Since the implementation of the US Modernization of Cosmetics Regulation Act (MoCRA) in 2022, safety evaluation of cosmetic products has become even more essential for personal care products. The act, the most significant development in cosmetic safety since the Federal Food, Drug and Cosmetic (FD&C) Act in 1938, states that companies marketing cosmetic products are responsible for ensuring their safety.

In this complimentary webinar, presenters Joseph Scognamiglio and Frédéric Nunzi will give attendees an expert overview of the risk assessment process for cosmetics, discussing key toxicology principles and detailing the in vitro testing toolbox for cosmetic product safety assessments.

Non-clinical methods will also be explored, including toxicological risk assessment and in vitro techniques, which can be used to support the safety dossier of a cosmetic product.

Agenda

• Why risk assessments matter
• Core elements of a risk assessment
• Key toxicology principles
• Risk assessment process
• In vitro tests for cosmetic formulations
• Q&A

Who should attend:

This webinar is aimed at cosmetic manufacturers, producers, product stewards and personnel involved with the safety and regulatory compliance of non-clinical cosmetic products.

Register now

This one-hour event takes place on April 16, 2025, at 10:00 am (EST).

For further information, please contact:

Jennifer Buckley
Senior Global Marketing Manager
Food, Cosmetics & Personal Care
t: +1 973 461 1498